SREBF2 and metabolic syndrome: Sterol regulatory element binding transcription factor 2 (SREBF2) gene (OMIM ID: 600481) and insulin-induced gene2 (INSIG2) (OMIM ID: 608660) polymorphisms were found to be associated with dyslipidemia in patients treated with risperidone (Vanwong et al., 2021).